Cultural Origin and Minority Shareholder Expropriation: Historical Evidence
Journal of Accounting Research · 2024-03 · 62 (1) · 181-228
DOI: 10.1111/1475-679x.12517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Accounting Research, online erschienen am 27.11.2023. Verfasst von ZHIHUI GU und 2 weiteren Autor:innen. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Can culture explain regional differences in minority shareholder expropriation? Examining regional variation in China, we document that the influence of historical Confucian values persists, despite decades of political movements clamping down on these values, and that these values reduce minority shareholder expropriation in local public firms. The effect on minority shareholder expropriation, in part, operates through the establishment of oversight mechanisms (i.e., greater financial reporting quality and dividend payouts) that constrain expropriation. The findings have important implications for understanding the origins of enduring regional differences in minority shareholder expropriation and capital market development.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
GU, Z., SUN, W., & ZHOU, F. S. (2024). Cultural Origin and Minority Shareholder Expropriation: Historical Evidence. Journal of Accounting Research, 62(1), 181-228. https://doi.org/10.1111/1475-679x.12517
Vancouver
GU Z, SUN W, ZHOU FS. Cultural Origin and Minority Shareholder Expropriation: Historical Evidence. Journal of Accounting Research. 2024;62(1):181-228. doi:10.1111/1475-679x.12517
BibTeX
@article{GU2024,
author = {GU, ZHIHUI and SUN, WEI and ZHOU, FRANK S.},
title = {Cultural Origin and Minority Shareholder Expropriation: Historical Evidence},
journal = {Journal of Accounting Research},
year = {2024},
volume = {62},
number = {1},
pages = {181--228},
doi = {10.1111/1475-679x.12517}
}
EUVIMED